 | • レポートコード：MRC2106A196 • 出版社/出版日：Mordor Intelligence / 2021年5月25日 • レポート形態：英文、PDF、119ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療 |
| Single User | ￥629,000 (USD4,250) | ▷ お問い合わせ |
| Team User | ￥703,000 (USD4,750) | ▷ お問い合わせ |
| Corporate License | ￥1,110,000 (USD7,500) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査資料は、世界のマンモグラフィー市場について調査し、イントロダクション、調査手法、エグゼクティブサマリー、市場動向、製品タイプ別（デジタルシステム、アナログシステム、乳房トモシンセシス、その他）分析、エンドユーザー別（病院、専門クリニック、診断センター）分析、地域別分析、競争状況、市場機会/将来の見通しなどを徹底分析したものです。 ・イントロダクション ・調査手法 ・エグゼクティブサマリー ・市場動向 ・世界のマンモグラフィー市場規模：製品タイプ別（デジタルシステム、アナログシステム、乳房トモシンセシス、その他） ・世界のマンモグラフィー市場規模：エンドユーザー別（病院、専門クリニック、診断センター） ・世界のマンモグラフィー市場規模：地域別 ・競争状況 ・市場機会/将来の見通し |
The mammography market is projected to register a CAGR of 8.97% during the forecast period, with a revenue of approximately USD 1,823.13 million in 2020 and expected to reach USD 3,215 million by 2026.
The COVID-19 pandemic has been continuing to transform the growth of various markets, the immediate impact of the outbreak is varied. While a few industries registered a drop in demand, numerous other markets may continue to remain unscathed and show promising growth opportunities. Initially, the outbreak of COVID-19 showed a strong impact on the Mammography market because hospital and healthcare services were significantly reduced due to social distancing measures taken by governments across the globe. Moreover, the COVID-19 pandemic not only affected the global economy but also showed a huge impact on the functioning of general hospital care for non-COVID-19 patients in hospitals across the globe. As many hospitals and screening centers remain closed due to lockdowns, the demand for mammography procedures is expected to be subdued in the short term. According to an article appearing in the JAMA Network in August 2020, there has been a significant decline in breast cancer diagnoses (by as much as 51.8 percent) in the United States from March 1, 2020 to April 18, 2020. This is expected to have had a negative impact on mammography device manufacturers as their demand has reduced significantly.
Moreover, the major factors responsible for the growth of the mammography market include the growing prevalence of breast cancer, technological advancements in the field of breast imaging, and investment from various organizations in breast cancer screening campaigns.
According to the Centers for Disease Control and Prevention (CDC) reports 2018, breast cancer is one of the most common cancers among women, irrespective of race or ethnicity. It is also the third most common cause of death from cancer among American Indian/Alaska Native women.
According to a Globocan report in 2020, breast cancer was the most prevalent types of cancer with a prevalence rate of 11.7%. According to the same report, the five-year prevalence rate for both the sexes showed that Asia had the the highest number of people affected at 3,218,496 (41.3%), followed by Europe at 2,138,117 (27.4%) and North America with 1.189,111 people (15.3%). Such high prevalence rates of breast cancer is one of the main reasons why demand for mammography devices are expected to increase, as they will be used for diagnostic purposes. Furthermore, as the global population is aging, a large number of women are expected to move into the 60 and above age category. Women aged 60 years and above account for almost 78% of all breast cancer-related deaths. High-incidence and mortality rates for breast cancer in this age group represent a huge unmet need for breast cancer diagnostics. As the number of incidents and mortality cases is increasing, the demand for mammography is also expected to increase. This remains a major driver for the mammography market and is expected to boost the market during the forecast period.
However, the adverse effects from radiation exposure and risks associated with mammography are expected to pull back the market growth, over the forecast period.
Key Market Trends
The Digital Mammography Segment is Expected to Account for the Largest Market Share During the Forecast Period
As breast cancer patients are at higher risk of acquiring the infection, many of the organizations took definite measures for the management of these diseases. According to a research article by Dafina Petrova et al., published in Medicina Clínica Journal September 2020, the European Society for Medical Oncology (ESMO), the Spanish Society of Radiation Oncology (SEOR), and the Spanish Society of Medical Oncology (SEOM) have published some recommendations on how to modify treatment protocols to minimize risks in cancer patients. Such instances are expected to support the growth of digital mammography market.
Digital mammography is a specialized and advanced form of mammography that uses digital receptors and computers instead of X-ray films to examine breast tissue for the presence of tumors. So far, conventional screen-film mammography (SFM) with high-spatial resolution has been the preferred choice for screening programs in most countries. However, with the advent of digital mammography, an increasing number of countries are experiencing shifts toward these newer systems, due to their superior depiction of low-contrast objects, wider dynamic change, and improved diagnostic quality of images, especially when examining denser breasts. They also come with an added advantage of soft-copy image displays and soft-copy reading, which can be easily transferred. Mammography screening in various countries, such as in the United Kingdom, is now digital, which offers greater precision, better quality, and higher efficiency. Thus, digital mammography is becoming the preferred choice of screening, even though the cost of the new technology is six times higher than the conventional systems. Radiation exposure is significantly lower as compared to analog systems. Full-field digital mammography is the most common form of digital mammography employed. It offers the potential for significant advances in breast cancer diagnosis, including lower radiation dosages, reduced breast compression pressure, and improved detection. All these advantages aid in the growth of the market over the forecast period.
Moreover, . As per American Cancer Society, In 2019, there were around 8,130 Ductal carcinomas in situ (DCIS) and 37,150 invasive breast cancer new cases among females aged between 40 to 49 years reported in United States. Thus, the rising prevalence of breast cancer will boost the demand for digital mammography.
North America Accounts for the Largest Share in the Global Market
North America is found to hold a major share of the mammography market, and it is expected to show a similar trend over the forecast period, without significant fluctuations. The rising prevalence of breast cancer and the presence of better healthcare infrastructure in the region are expected to drive the overall growth of the market over the forecast period.
Due to the outbreak of COVID-19, the market is expected to face a slight setback owing to the delay in diagnosis, drug shortages, and others. However, As lockdowns and restrictions are getting relaxed. there will be an increase in demand for mammography services. Many women who had canceled their appointments or had their visits for mammography services postponed are now able to get their tests done. The Breast Cancer Research Foundation in the United States has stated that hospitals and facilities in most places are well prepared and safe now as compared to the initial days of the COVID-19 pandemic. Thus, it has been encouraging women to get their scheduled scans done so that diagnosis is not delayed.
According to the American Cancer Society, in 2020, an estimated 276,480 new cases of invasive breast cancer have been diagnosed among women. In addition, 48,530 cases of in situ breast carcinoma have been diagnosed among women and the number of breast cancer cases is expected to increase in the coming years. Furthermore, several companies are also found launching programs to support breast cancer tests. For example in August 2020, Hologic, Inc has announced the launch of Back to Screening campaign which will encourage women to schedules their delayed mammogram due to COVID-19 Pandemic. In the United States, the National Breast Cancer Foundation (NBCF) is the organization that provides breast cancer education and free mammograms to women in need. This organization conducts various programs, such as National Mammography Program, Beyond The Shock, Patient Navigation, and Breast Health Awareness. Thus, owing to the rising prevalence of breast cancer and awareness among the population, the market is expected to experience growth over the forecast period.
Competitive Landscape
The mammography market is a consolidated one, owing to the presence of a few major players in the market. The major market players are focusing on technological advancements and reducing the side effects of the procedures. Some of the major players in the market are Analogic Corporation, Canon Medical Systems Corporation, Fujifilm Corporation, GE Healthcare, Hologic Inc., Koninklijke Philips NV, and Siemens Healthineers.
Reasons to Purchase this report:
– The market estimate (ME) sheet in Excel format
– 3 months of analyst support
1 INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Growing Prevalence of Breast Cancer
4.2.2 Technological Advancements in the Field of Breast Imaging
4.2.3 Investment from Various Organizations in Breast Cancer Screening Campaigns
4.3 Market Restraints
4.3.1 Risk of Adverse Effects from Radiation Exposure
4.3.2 Reduction in Reimbursement
4.4 Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Product Type
5.1.1 Digital Systems
5.1.2 Analog Systems
5.1.3 Breast Tomosynthesis
5.1.4 Other Product Types
5.2 By End Users
5.2.1 Hospitals
5.2.2 Specialty Clinics
5.2.3 Diagnostic Centers
5.3 Geography
5.3.1 North America
5.3.1.1 United States
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.2 Europe
5.3.2.1 Germany
5.3.2.2 United Kingdom
5.3.2.3 France
5.3.2.4 Italy
5.3.2.5 Spain
5.3.2.6 Rest of Europe
5.3.3 Asia-Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 South Korea
5.3.3.6 Rest of Asia-Pacific
5.3.4 Middle East and Africa
5.3.4.1 GCC
5.3.4.2 South Africa
5.3.4.3 Rest of Middle East and Africa
5.3.5 South America
5.3.5.1 Brazil
5.3.5.2 Argentina
5.3.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Fujifilm Holdings Corporation
6.1.2 GE Healthcare
6.1.3 Hologic Inc.
6.1.4 General Medical Merate S.P.A.
6.1.5 Koninklijke Philips NV
6.1.6 Metaltronica SpA
6.1.7 Konica Minolta Inc.
6.1.8 Planmed Oy
6.1.9 Siemens Healthineers
6.1.10 Carestream Health
6.1.11 Canon Medical Systems Corporation
6.1.12 Toshiba Medical Systems
6.1.13 Mindray Medical International Limited
6.1.14 Quest Diagnostics Incorporated
7 MARKET OPPORTUNITIES AND FUTURE TRENDS